| 1 | MRNA | Moderna, Inc. | 5.87% |
| 2 | GILD | Gilead Sciences, Inc. | 4.27% |
| 3 | AMGN | Amgen Inc. | 4.05% |
| 4 | BNTX | BioNTech SE | 3.62% |
| 5 | VRTX | Vertex Pharmaceuticals Incorporated | 3.59% |
| 6 | BMRN | BioMarin Pharmaceutical Inc. | 3.57% |
| 7 | UTHR | United Therapeutics Corporation | 3.54% |
| 8 | KRYS | Krystal Biotech, Inc. | 3.53% |
| 9 | EXAS | Exact Sciences Corporation | 3.53% |
| 10 | BIIB | Biogen Inc. | 3.53% |
| 11 | REGN | Regeneron Pharmaceuticals, Inc. | 3.45% |
| 12 | ALKS | Alkermes plc | 3.44% |
| 13 | NBIX | Neurocrine Biosciences, Inc. | 3.43% |
| 14 | HALO | Halozyme Therapeutics, Inc. | 3.37% |
| 15 | CORT | Corcept Therapeutics Incorporated | 3.32% |
| 16 | ARGX | argenx SE | 3.32% |
| 17 | EXEL | Exelixis, Inc. | 3.30% |
| 18 | INCY | Incyte Corporation | 3.22% |
| 19 | ILMN | Illumina, Inc. | 3.19% |
| 20 | ONC | BeOne Medicines AG | 3.08% |
| 21 | TECH | Bio-Techne Corporation | 3.07% |
| 22 | ACAD | ACADIA Pharmaceuticals Inc. | 3.04% |
| 23 | NTRA | Natera, Inc. | 3.02% |
| 24 | VCYT | Veracyte, Inc. | 3.01% |
| 25 | GMAB | Genmab A/S | 2.87% |
| View FBT holdings |
